A citation-based method for searching scientific literature

Juan Pablo Frias, Michael A Nauck, Joanna Van, Charles Benson, Ross Bray, Xuewei Cui, Zvonko Milicevic, Shweta Urva, Axel Haupt, Deborah A Robins. Diabetes Obes Metab 2020
Times Cited: 57



Alice E Adriaenssens, Emma K Biggs, Tamana Darwish, John Tadross, Tanmay Sukthankar, Milind Girish, Joseph Polex-Wolf, Brain Y Lam, Ilona Zvetkova, Warren Pan, Davide Chiarugi, Giles S H Yeo, Clemence Blouet, Fiona M Gribble, Frank Reimann. Cell Metab 2019
Times Cited: 93




List of shared articles



Times cited


Anti-obesity drug discovery: advances and challenges.
Timo D Müller, Matthias Blüher, Matthias H Tschöp, Richard D DiMarchi. Nat Rev Drug Discov 2022
77



Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.
Julio Rosenstock, Carol Wysham, Juan P Frías, Shizuka Kaneko, Clare J Lee, Laura Fernández Landó, Huzhang Mao, Xuewei Cui, Chrisanthi A Karanikas, Vivian T Thieu. Lancet 2021
110

Treatment of type 2 diabetes: challenges, hopes, and anticipated successes.
Michael A Nauck, Jakob Wefers, Juris J Meier. Lancet Diabetes Endocrinol 2021
29

The gut hormone receptor GIPR links energy availability to the control of hematopoiesis.
Gemma Pujadas, Elodie M Varin, Laurie L Baggio, Erin E Mulvihill, K W Annie Bang, Jacqueline A Koehler, Dianne Matthews, Daniel J Drucker. Mol Metab 2020
6


Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes.
Qiming Tan, Seun E Akindehin, Camila E Orsso, Richelle C Waldner, Richard D DiMarchi, Timo D Müller, Andrea M Haqq. Front Endocrinol (Lausanne) 2022
10

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models.
Tito Borner, Caroline E Geisler, Samantha M Fortin, Richard Cosgrove, Jorge Alsina-Fernandez, Mridula Dogra, Sarah Doebley, Marcos J Sanchez-Navarro, Rosa M Leon, Jane Gaisinsky,[...]. Diabetes 2021
21



Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?
Tito Borner, Ian C Tinsley, Robert P Doyle, Matthew R Hayes, Bart C De Jonghe. Br J Pharmacol 2022
8